This page lists all pharmaceutical reports related to the field of Immunology & Inflammatory Diseases. The reports include market research reports and pipeline analyses.
Displaying 51 - 100 of 215 results
- Psoriasis - Biologics Impact Treatment Regimes Across the Globe
- Stakeholder Insight: Asthma - Combination Therapy Appropriate for Everyone?
- Systemic Lupus Erythematosus - On the Verge of a Breakthough
- Immunotherapy in Allergic Rhinitis
- Kidney Transplantation - Switching to calcineurin inhibitor-free immunosuppression
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Multiple Sclerosis - Continued growth makes the MS market a highly attractive investment
- Cell-Based Assays for Drug Discovery
- Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential
- ALLERGY - Therapy Area Pipeline Report
- ARTHRITIS - Therapy Area Pipeline Report
- AUTOIMMUNE DISEASES - Therapy Area Pipeline Report
- CROHN DISEASE - Therapy Area Pipeline Report
- INFLAMMATION - Therapy Area Pipeline Report
- LUPUS - Therapy Area Pipeline Report
- RHEUMATOID ARTHRITIS - Therapy Area Pipeline Report
- ORGAN TRANSPLANTATION - Therapy Area Pipeline Report
- MULTIPLE SCLEROSIS - Therapy Area Pipeline Report
- ECZEMA - Therapy Area Pipeline Report
- ULCERATIVE COLITIS - Therapy Area Pipeline Report
- TYPE 1 DIABETES - Therapy Area Pipeline Report
- OSTEOARTHRITIS - Therapy Area Pipeline Report
- OCULAR INFLAMMATION - Therapy Area Pipeline Report
- ASTHMA - Therapy Area Pipeline Report
- BRONCHITIS - Therapy Area Pipeline Report
- BRONCHOSPASM - Therapy Area Pipeline Report
- CHRONIC OBSTRUCTIVE PULMONARY DISEASE - Therapy Area Pipeline Report
- COUGH - Therapy Area Pipeline Report
- NASAL CONGESTION - Therapy Area Pipeline Report
- GINGIVITIS and PERIODONTITIS - Therapy Area Pipeline Report
- Autoimmune Market Outlook to 2012
- Monoclonal Antibodies: strategic analysis of the mAb market out to 2012
- The Future of Biosimilars: Key opportunities & emerging therapies
- Top Companies and Products in the RNA/DNA Therapy Products Market
- Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
- Commercial and Pipeline Insight: Allergic Rhinitis
- Biosimilars Series: Strategic issues - Potential remains uncertain
- Immunomodulators: Therapeutic Needs, Pipelines and Prospects
- Translational Medicine in Biopharmaceutical Research and Development
- Multiple Sclerosis Market Analysis and Forecasts Report 2007-2022
- The Gastrointestinal Market Outlook to 2012
- Licensing Strategies - Current Pharmaceutical Licensing Trends
- Pediatric Drugs - the Worldwide Market
- Autoimmune Disorders and Transplant Rejection - The Potential of T-cells Targeted Therapeutics
- Rheumatoid arthritis - Emerging drug discovery targets and therapeutic candidates
- Asthma Therapeutics - New treatment options and emerging drug discovery targets
- BAFF (BLys) and APRIL: Emerging Targets for autoimmune disease & Cancer Therapeutics
- Coxibs - Past Problems and Future Potential
- Disease Modifying Osteoarthritis Drugs - The Search for the Holy Grail Continues
- Tysabri - Can Efficacy of VLA-4 Mechanism Overcome Safety Concerns?